CAESARSTONE LTD (CSTE)
IL0011259137 - Common Stock
CSTE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 43 industry peers in the Building Products industry. The financial health of CSTE is average, but there are quite some concerns on its profitability. CSTE is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CSTE had negative earnings in the past year.
In the past year CSTE had a positive cash flow from operations.
In multiple years CSTE reported negative net income over the last 5 years.
CSTE had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CSTE's Return On Assets of -18.58% is on the low side compared to the rest of the industry. CSTE is outperformed by 88.37% of its industry peers.
CSTE has a Return On Equity of -33.59%. This is amonst the worse of the industry: CSTE underperforms 88.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.58% | ||
| ROE | -33.59% | ||
| ROIC | N/A |
ROA(3y)-7.99%
ROA(5y)-4.25%
ROE(3y)-14.39%
ROE(5y)-7.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CSTE's Gross Margin of 16.27% is on the low side compared to the rest of the industry. CSTE is outperformed by 88.37% of its industry peers.
CSTE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CSTE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.27% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.09%
GM growth 5Y-10.53%
2. Health
2.1 Basic Checks
CSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CSTE has more shares outstanding
CSTE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CSTE has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.13 indicates that CSTE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CSTE (2.13) is worse than 79.07% of its industry peers.
CSTE has a debt to FCF ratio of 0.14. This is a very positive value and a sign of high solvency as it would only need 0.14 years to pay back of all of its debts.
CSTE has a better Debt to FCF ratio (0.14) than 88.37% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that CSTE is not too dependend on debt financing.
The Debt to Equity ratio of CSTE (0.01) is better than 83.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | 2.13 |
ROIC/WACCN/A
WACC8.51%
2.3 Liquidity
CSTE has a Current Ratio of 2.64. This indicates that CSTE is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.64, CSTE is doing good in the industry, outperforming 65.12% of the companies in the same industry.
CSTE has a Quick Ratio of 1.51. This is a normal value and indicates that CSTE is financially healthy and should not expect problems in meeting its short term obligations.
CSTE has a Quick ratio of 1.51. This is in the better half of the industry: CSTE outperforms 62.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.64 | ||
| Quick Ratio | 1.51 |
3. Growth
3.1 Past
The earnings per share for CSTE have decreased strongly by -506.06% in the last year.
Looking at the last year, CSTE shows a very negative growth in Revenue. The Revenue has decreased by -18.18% in the last year.
CSTE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.37% yearly.
EPS 1Y (TTM)-506.06%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1300%
Revenue 1Y (TTM)-18.18%
Revenue growth 3Y5.13%
Revenue growth 5Y-0.37%
Revenue growth Q2Q-19.37%
3.2 Future
The Earnings Per Share is expected to grow by 36.63% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -2.37% on average over the next years.
EPS Next Y69.93%
EPS Next 2Y36.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.72%
Revenue Next 2Y-2.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CSTE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSTE. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CSTE is valued cheaply inside the industry as 97.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.01 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CSTE's earnings are expected to grow with 36.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.63%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CSTE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CAESARSTONE LTD
NASDAQ:CSTE (5/3/2024, 12:35:07 PM)
6.425
+0.04 (+0.55%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap221.92M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.58% | ||
| ROE | -33.59% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 16.27% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.64 | ||
| Quick Ratio | 1.51 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-506.06%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y69.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-18.18%
Revenue growth 3Y5.13%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y